表纸SALE
市场调查报告书

医药品开发、临床试验AI - 全球市场:2020年

AI in Drug Development & Clinical Trials - World - 2020

出版商 Signify Research 商品编码 949933
出版日期 内容资讯 英文
商品交期: 最快1-2个工作天内
价格
医药品开发、临床试验AI - 全球市场:2020年 AI in Drug Development & Clinical Trials - World - 2020
出版日期: 将在2020年10月30日内容资讯: 英文
简介

本报告提供以下的内容。

报告概要

市场

  • 产品和最终市场
  • 推动市场要素与成长的障碍
  • 市场规模与成长预测

技术

  • AI应用的市场分析
  • 先进的机器学习和深度学习的影响
  • 下一代DNA定序、处理技术的影响

竞争

  • 主要供应商的市场占有率估计
  • 主要供应商的详细介绍,SWOT分析
  • 潜在的合作伙伴与收购目标

目录

2019年~2024年的市场指标

市场明细:各主要地区、国家

  • 南北美洲
    • 美国
    • 加拿大
    • 巴西
    • 墨西哥
    • 其他南美
  • 欧洲、中东、非洲
    • 荷比卢三国
    • 法国
    • DACH
    • 义大利
    • 北欧
    • 英国/爱尔兰
    • 西班牙/葡萄牙
    • 东欧
    • 中东
    • 非洲
  • 亚洲
    • 大洋洲
    • 印度
    • 韩国

各国的市场明细:各系列产品

  • 产品类型
    • 资讯、疾病模式
    • 医药品设计、最佳化
    • 前临床、临床试验
  • 产品零组件
    • 软体
    • 硬体设备
    • 服务
  • 授权模式
    • 永久许可证
    • 订阅许可证
    • 各研究的费用
    • 伙伴关系

各产品的明细:各临床应用

  • 肿瘤
  • 神经
  • 感染疾病
  • 其他/整体

各产品的明细:各架构

  • 内部部署(含私有云端)
  • 云端(托管)
目录

Report Overview

Market

  • Identify the products and end-markets driving growth
  • Review the market drivers and barriers for growth
  • Quantitative analysis of market size and forecast growth

Technology

  • Market analysis for AI applications in information and disease models, drug design & optimisation, preclinical & clinical trials
  • Impact of advanced machine learning and deep learning
  • Influence of next generation DNA sequencing and processing technologies

Competition

  • Market share estimates for the leading vendors
  • Detailed profiles of selected vendors, with SWOT analysis for each
  • Identify potential partners and acquisition targets

Strategy

  • Review go-to-market strategies
  • Analysis and insights to support your strategy and business planning
  • Product pricing and software delivery strategies

Report Features:

  • Expert commentary on the market Trends
  • Primary research method ensures accuracy and reliability
  • Direct access to the lead Analyst
  • Highly data-centric, with numerous segmentations of the market
  • Detailed analysis by product, sales model and application to highlight growth opportunities
  • Robust forecasts driven by proprietary database of hospital infrastructure
  • Report focused on global market coverage with detailed country analysis
  • Actionable, jargon-free analyst insight and opinion

Key issues Addressed:

  • How large is the global market for AI in drug development in terms of revenue and how will this change over the next five years?
  • How does the market break out in terms of applications for information synthesis, drug design and clinical trials?
  • How does the market break out in terms of clinical areas (oncology, neurology, infectious disease, other)?
  • How is the market split between licencing models?
  • What are the main drivers behind each market segment?
  • Who are the leading vendors and what is needed to stay competitive?

Table of Contents

This is the preliminary research scope. The below outlines market splits that are being considered for inclusion in the scope.

Market metrics presented for the period 2019 to 2024.

The report is primarily organised by Product Group, with dedicated chapters for the following:

  • Information & Disease Models (AI based applications to: aggregate and synthesize information, understand mechanisms of disease, establish biomarkers, generate data and models)
  • Drug Design & Optimisation (AI applications to: repurpose existing drugs, generate novel drug candidates, validate and optimise drug candidates, design drugs)
  • Preclinical & Clinical Trials (AI applications to: design preclinical experiments, run preclinical experiments, design clinical trials, recruit for clinical trials, optimise clinical trials, publish data, analyse real world evidence)

The market will be broken down by Geographic Region into the following major regions and countries/subregions:

  • Americas
    • US
    • Canada
    • Brazil
    • Mexico
    • Rest of Latin America
  • EMEA
    • Benelux
    • France
    • DACH
    • Italy
    • Nordics
    • UK/Eire
    • Spain/Portugal
    • E. Europe
    • Middle East
    • Africa
  • Asia
    • Oceania
    • India
    • South Korea

For each country the market is segmented by Product Group into:

  • Product Type
    • Information & Disease Models
    • Drug Design & Optimisation
    • Preclinical & Clinical Trials
  • Product Component
    • Software
    • Hardware
    • Service
  • Licensing Model
    • Perpetual License
    • Subscription License
    • Fee per Study
    • Partnership

Each product is then further segmented by Clinical Application into:

  • Oncology
  • Neurology
  • Infectious Disease
  • Other/General

Each product is then further segmented by Architecture into:

  • On-Premise (inc. private cloud)
  • Cloud (hosted)